We seek to invest in founder-owned healthcare companies in the lower middle market and bring deep sector knowledge, a network of relationships, and experience building businesses to transform our portfolio companies.
Technology, software, and tech-enabled services that improve healthcare delivery, operations, and outcomes.
Specialized services and technology that improve provider operations, reimbursement, and financial performance.
Outsourced services supporting the discovery, development, testing, and production of pharmaceutical and biotechnology products.
Services supporting the successful launch, adoption, and ongoing optimization of pharmaceutical and biotechnology products.
Outsourced services supporting the design, development, manufacturing, and commercialization of medical products and healthcare technologies.
Critical infrastructure supporting the storage, movement, and delivery of healthcare products.
Our team has refined our investment approach across
six funds and more than three decades. It’s built on three deliberate phases.
We earn the trust of founders by bringing sector expertise, alignment, and a collaborative approach.
We arrive with a value creation plan developed before closing and ready to execute from day one.
We work towards exits that intend to position our portfolio companies for long-term success in their respective markets.
Our Healthcare Advisory Board brings together operating executives, industry veterans, and sector experts from leading organizations who actively contribute to our investment process and help our companies build value.
Our Clinical Advisory Board is composed of practicing physicians and department chairs from leading hospitals and academic medical centers who bring a ground-level clinical perspective to our process and serve as resources for navigating complex clinical environments.
Artificial intelligence is reshaping the healthcare sector and our portfolio companies are navigating this shift. Our AI Advisory Board brings together experts who advise on AI strategy and helps RS2 stay current in a rapidly evolving landscape.
